Jounce Therapeutics Inc (21J) : Analyse, Valorisation, Dividende et Ratios Financiers

Jounce Therapeutics Inc

21JStockF

€—

2

Jounce Therapeutics Inc

€—

21JStockF

Arberion© 2026

Arberion

Loading market data